The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub’s thin end. Batch number 9238 is printed on the product packaging.
Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly.
Online at Amazon.com from October 2019 through February 2020 for about $25.
SeeNext Venture Ltd., of Blaine, Wash.
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risks of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product incidents cost the nation more than $1 trillion annually. CPSC’s work to ensure the safety of consumer products has contributed to a decline in the rate of deaths and injuries associated with consumer products over the past 40 years.
Federal law bars any person from selling products subject to a publicly announced voluntary recall by a manufacturer or a mandatory recall ordered by the Commission.
For lifesaving information:
Please use the below phone number for all media requests.
Phone: (301) 504-7908
Spanish: (301) 504-7800